The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 06, 2021

Filed:

Dec. 05, 2016
Applicant:

The Regents of the University of California, Oakland, CA (US);

Inventors:

Madhuri Wadehra, Fontana, CA (US);

Jonathan Braun, Tarzana, CA (US);

Assignee:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/30 (2006.01); A61K 39/00 (2006.01); C07K 16/28 (2006.01); A61K 47/68 (2017.01); G01N 33/574 (2006.01); G01N 33/577 (2006.01); A61P 35/00 (2006.01); C07K 16/22 (2006.01);
U.S. Cl.
CPC ...
C07K 16/28 (2013.01); A61K 47/6803 (2017.08); A61K 47/6849 (2017.08); A61K 47/6851 (2017.08); A61P 35/00 (2018.01); C07K 16/22 (2013.01); C07K 16/2863 (2013.01); C07K 16/30 (2013.01); G01N 33/574 (2013.01); G01N 33/577 (2013.01); G01N 33/57492 (2013.01); A61K 2039/505 (2013.01); C07K 2317/40 (2013.01); C07K 2317/565 (2013.01); C07K 2317/73 (2013.01); C07K 2317/92 (2013.01); C07K 2317/94 (2013.01); G01N 2333/705 (2013.01);
Abstract

Provided herein are novel anti-EMP2 antibodies useful for the treatment and diagnosis of cancers that express or overexpress EMP2. In one aspect, provided herein is an isolated antibody that binds to Epithelial Membrane Protein 2 (EMP2), that includes heavy chain variable region and a light chain variable region. The heavy chain variable region includes three heavy chain complementary determining regions (HCDRs) and the light chain variable region includes three light chain variable regions (LCDRs). In some embodiments, the sequence of HCDR1 is SEQ ID NO: 11, the sequence of HCDR2 is SEQ ID NO: 12, the sequence of HCDR3 is SEQ ID NO: 13, the sequence of LCDR1 is SEQ ID NO:14, the sequence of LCDR2 is SEQ ID NO: 15, and the sequence of LCDR3 is SEQ ID NO: 16.


Find Patent Forward Citations

Loading…